GLP-1 Autoinjectors Market Report – Research, Industry Analysis Reports and Market Demands

Global GLP-1 Autoinjectors Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global GLP-1 Autoinjectors Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Fixed-Dose Autoinjector
- 1.3.3 Multidose Pen Injector
- 1.3.4 Dose-Selectable Pen
1.4 Market Analysis by Use Cycle
- 1.4.1 Overview: Global GLP-1 Autoinjectors Consumption Value by Use Cycle: 2021 Versus 2025 Versus 2032
- 1.4.2 Single-Use Disposable
- 1.4.3 Reusable Base with Replaceable Cartridge
1.5 Market Analysis by Therapeutic Indication
- 1.5.1 Overview: Global GLP-1 Autoinjectors Consumption Value by Therapeutic Indication: 2021 Versus 2025 Versus 2032
- 1.5.2 Obesity Treatment
- 1.5.3 Type 2 Diabetes
- 1.5.4 Others
1.6 Market Analysis by Application
- 1.6.1 Overview: Global GLP-1 Autoinjectors Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Pharmaceutical
- 1.6.3 CDMO
- 1.6.4 Others
1.7 Global GLP-1 Autoinjectors Market Size & Forecast
- 1.7.1 Global GLP-1 Autoinjectors Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global GLP-1 Autoinjectors Sales Quantity (2021-2032)
- 1.7.3 Global GLP-1 Autoinjectors Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: GLP-1 Autoinjectors by Manufacturer

3.1 Global GLP-1 Autoinjectors Sales Quantity by Manufacturer (2021-2026)
3.2 Global GLP-1 Autoinjectors Revenue by Manufacturer (2021-2026)
3.3 Global GLP-1 Autoinjectors Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of GLP-1 Autoinjectors by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 GLP-1 Autoinjectors Manufacturer Market Share in 2025
- 3.4.3 Top 6 GLP-1 Autoinjectors Manufacturer Market Share in 2025
3.5 GLP-1 Autoinjectors Market: Overall Company Footprint Analysis
- 3.5.1 GLP-1 Autoinjectors Market: Region Footprint
- 3.5.2 GLP-1 Autoinjectors Market: Company Product Type Footprint
- 3.5.3 GLP-1 Autoinjectors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global GLP-1 Autoinjectors Market Size by Region
- 4.1.1 Global GLP-1 Autoinjectors Sales Quantity by Region (2021-2032)
- 4.1.2 Global GLP-1 Autoinjectors Consumption Value by Region (2021-2032)
- 4.1.3 Global GLP-1 Autoinjectors Average Price by Region (2021-2032)
4.2 North America GLP-1 Autoinjectors Consumption Value (2021-2032)
4.3 Europe GLP-1 Autoinjectors Consumption Value (2021-2032)
4.4 Asia-Pacific GLP-1 Autoinjectors Consumption Value (2021-2032)
4.5 South America GLP-1 Autoinjectors Consumption Value (2021-2032)
4.6 Middle East & Africa GLP-1 Autoinjectors Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global GLP-1 Autoinjectors Sales Quantity by Type (2021-2032)
5.2 Global GLP-1 Autoinjectors Consumption Value by Type (2021-2032)
5.3 Global GLP-1 Autoinjectors Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global GLP-1 Autoinjectors Sales Quantity by Application (2021-2032)
6.2 Global GLP-1 Autoinjectors Consumption Value by Application (2021-2032)
6.3 Global GLP-1 Autoinjectors Average Price by Application (2021-2032)

7 North America

7.1 North America GLP-1 Autoinjectors Sales Quantity by Type (2021-2032)
7.2 North America GLP-1 Autoinjectors Sales Quantity by Application (2021-2032)
7.3 North America GLP-1 Autoinjectors Market Size by Country
- 7.3.1 North America GLP-1 Autoinjectors Sales Quantity by Country (2021-2032)
- 7.3.2 North America GLP-1 Autoinjectors Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe GLP-1 Autoinjectors Sales Quantity by Type (2021-2032)
8.2 Europe GLP-1 Autoinjectors Sales Quantity by Application (2021-2032)
8.3 Europe GLP-1 Autoinjectors Market Size by Country
- 8.3.1 Europe GLP-1 Autoinjectors Sales Quantity by Country (2021-2032)
- 8.3.2 Europe GLP-1 Autoinjectors Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific GLP-1 Autoinjectors Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific GLP-1 Autoinjectors Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific GLP-1 Autoinjectors Market Size by Region
- 9.3.1 Asia-Pacific GLP-1 Autoinjectors Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific GLP-1 Autoinjectors Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America GLP-1 Autoinjectors Sales Quantity by Type (2021-2032)
10.2 South America GLP-1 Autoinjectors Sales Quantity by Application (2021-2032)
10.3 South America GLP-1 Autoinjectors Market Size by Country
- 10.3.1 South America GLP-1 Autoinjectors Sales Quantity by Country (2021-2032)
- 10.3.2 South America GLP-1 Autoinjectors Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa GLP-1 Autoinjectors Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa GLP-1 Autoinjectors Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa GLP-1 Autoinjectors Market Size by Country
- 11.3.1 Middle East & Africa GLP-1 Autoinjectors Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa GLP-1 Autoinjectors Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 GLP-1 Autoinjectors Market Drivers
12.2 GLP-1 Autoinjectors Market Restraints
12.3 GLP-1 Autoinjectors Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of GLP-1 Autoinjectors and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Autoinjectors
13.3 GLP-1 Autoinjectors Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 GLP-1 Autoinjectors Typical Distributors
14.3 GLP-1 Autoinjectors Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global GLP-1 Autoinjectors market size was valued at US$ 4445 million in 2025 and is forecast to a readjusted size of US$ 7527 million by 2032 with a CAGR of 8.0% during review period.
GLP-1 autoinjectors are prefilled or multidose pen-based drug delivery devices designed to administer GLP-1 receptor agonists or related incretin therapies through subcutaneous injection, mainly for diabetes and obesity treatment. They combine a high-value biologic or peptide drug with a user-friendly injection mechanism, enabling patients to self-administer weekly or daily doses with lower handling complexity than vial-and-syringe injection. In 2025, Global GLP-1 autoinjector sales are estimated at about 1,350 million units, with an average ex-works device value of about US$3.2 per unit. The industry chain runs from medical-grade polymers, springs, needles, glass cartridges/syringes and precision molds to pen injector design, device assembly, sterile filling, pharmaceutical combination-product registration, and diabetes/obesity drug distribution.
Demand is mainly driven by the rapid expansion of GLP-1 therapies from diabetes into chronic weight management, the shift of obesity treatment toward long-term self-administered medication, and patients' preference for convenient home injection. Supply-side growth is also reinforced by pharmaceutical companies’ need to reduce device-related bottlenecks, improve dose adherence, differentiate branded drugs through usability, and secure large-scale dual-sourcing capacity for high-volume GLP-1 launches.
This report is a detailed and comprehensive analysis for global GLP-1 Autoinjectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global GLP-1 Autoinjectors market size and forecasts, in consumption value ($ Million), sales quantity (million Units), and average selling prices (US$/Unit), 2021-2032
Global GLP-1 Autoinjectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (million Units), and average selling prices (US$/Unit), 2021-2032
Global GLP-1 Autoinjectors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (million Units), and average selling prices (US$/Unit), 2021-2032
Global GLP-1 Autoinjectors market shares of main players, shipments in revenue ($ Million), sales quantity (million Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Autoinjectors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Autoinjectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly and Company, Sanofi, Ypsomed, SHL Medical, Gerresheimer, Stevanato Group, Owen Mumford, Phillips-Medisize, Nemera, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
GLP-1 Autoinjectors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fixed-Dose Autoinjector
Multidose Pen Injector
Dose-Selectable Pen
Market segment by Use Cycle
Single-Use Disposable
Reusable Base with Replaceable Cartridge
Market segment by Therapeutic Indication
Obesity Treatment
Type 2 Diabetes
Others
Market segment by Application
Pharmaceutical
CDMO
Others
Major players covered
Novo Nordisk
Eli Lilly and Company
Sanofi
Ypsomed
SHL Medical
Gerresheimer
Stevanato Group
Owen Mumford
Phillips-Medisize
Nemera
Haselmeier
medmix
Bespak
Becton Dickinson
Terumo
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GLP-1 Autoinjectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 Autoinjectors, with price, sales quantity, revenue, and global market share of GLP-1 Autoinjectors from 2021 to 2026.
Chapter 3, the GLP-1 Autoinjectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 Autoinjectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and GLP-1 Autoinjectors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Autoinjectors.
Chapter 14 and 15, to describe GLP-1 Autoinjectors sales channel, distributors, customers, research findings and conclusion.

Buy now